Two year efficacy and pulmonary safety of inhaled insulin in patients with type 2 diabetes uncontrolled with oral agents

被引：0
|
作者：
Kuitert, L
Barnett, A
Pandya, S
Kon, P
机构：
[1] Barts & London NHS Trust, London, England
[2] Univ Birmingham, Birmingham B15 2TT, W Midlands, England
来源：
THORAX | 2005年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：II81 / II82
页数：2
相关论文
共 50 条
  • [1] Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes
    Rosenstock, Julio
    Cefalu, William T.
    Hollander, Priscilla A.
    Belanger, Andre
    Eliaschewitz, Freddy G.
    Gross, Jorge L.
    Klioze, Solomon S.
    Aubin, Lisa B. St.
    Foyt, Howard
    Ogawa, Masayo
    Duggan, William T.
    [J]. DIABETES CARE, 2008, 31 (09) : 1723 - 1728
  • [2] Efficacy and two-year pulmonary safety of inhaled insulin as adjunctive therapy with metformin or glibenclamide in Type 2 diabetes patients poorly controlled with oral monotherapy
    Dreyer, M
    [J]. DIABETOLOGIA, 2004, 47 : A44 - A45
  • [3] Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes
    Skyler, Jay S.
    Jovanovic, Lois
    Klioze, Sol
    Reis, Joann
    Duggan, William
    [J]. DIABETES CARE, 2007, 30 (03) : 579 - 585
  • [4] Inhaled insulin superior to rosiglitazone in patients with uncontrolled type 2 diabetes
    不详
    [J]. FORMULARY, 2003, 38 (07) : 408 - 408
  • [5] Efficacy and one-year pulmonary safety of inhaled insulin (Exubera®) as adjunctive therapy with metformin or glibenclamide in type 2 diabetes patients poorly controlled on oral agent monotherapy
    Barnett, AH
    [J]. DIABETES, 2004, 53 : A107 - A107
  • [6] Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents
    Rosenstock, Julio
    Bergenstal, Richard
    DeFronzo, Ralph A.
    Hirsch, Irl B.
    Klonoff, David
    Boss, Anders H.
    Kramer, David
    Petrucci, Richard
    Yu, Wen
    Levy, Brian
    [J]. DIABETES CARE, 2008, 31 (11) : 2177 - 2182
  • [7] Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
    Philis-Tsimikas, A.
    Del Prato, S.
    Satman, I.
    Bhargava, A.
    Dharmalingam, M.
    Skjoth, T. V.
    Rasmussen, S.
    Garber, A. J.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (08): : 760 - 766
  • [8] Efficacy and Safety of Insulin Glargine vs. NPH Insulin in Subjects With Type 2 Diabetes Mellitus Uncontrolled on Oral Agents: A Pooled Analysis of RCT Data
    Bolli, Geremia B.
    Porcellati, Francesca
    Lin, Jay
    Wang, Edward
    Lucidi, Paolo
    Fanelli, Carmine G.
    [J]. DIABETES, 2012, 61 : A265 - A265
  • [9] Inhaled insulin leads to a greater potential acceptance of insulin therapy in patients with uncontrolled Type 2 diabetes
    Freemantle, N
    Blonde, L
    Bolinder, B
    Hompesch, M
    Duhot, D
    Eggertsen, R
    Hobbs, EDR
    Martinez, L
    Ross, SA
    Stridde, E
    [J]. DIABETOLOGIA, 2004, 47 : A310 - A311
  • [10] Insulin degludec is superior to sitagliptin in improving glycaemic control in uncontrolled patients with type 2 diabetes on oral agents
    Philis-Tsimikas, A.
    Del Prato, S.
    Satman, I.
    Bhargava, A.
    Dharmalingam, M.
    Skjoth, T. V.
    Rasmussen, S.
    Garber, A. J.
    [J]. DIABETOLOGIA, 2012, 55 : S22 - S22
12345